What You Should Know:
- DeepScribe, a leader in ambient AI clinical documentation technology, is proud to announce its collaboration with Texas Oncology, a community-based oncology practice that covers most of Texas.
- Nearly 1,000 clinicians at more than 280 Texas Oncology locations will have the opportunity to use DeepScribe’s
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Mount Sinai, HealthSnap Partner to Expand Chronic Condition Management
What You Should Know:
- Mount Sinai Medical Center, the largest private, non-profit teaching hospital in Florida, and HealthSnap, a leading virtual care management platform, announced a significant expansion of their partnership.
- Building on the success of their initial Remote Patient Monitoring (RPM) program launched in March 2024, Mount Sinai is expanding to incorporate HealthSnap's Chronic Care Management (CCM) services across its primary care network.
Focus on Remote
Read More
InterSystems, CLEAR Integrate to Simplify Patient Data Access and Management
What You Should Know:
- InterSystems, a creative data technology provider dedicated to solving critical scalability, interoperability, and speed challenges for its customers, has announced a strategic partnership with CLEAR , the secure identity company.
- The partnership aims to integrate CLEAR’s Verified Identity
Read More
Tampa General Hospital Deploys AI Tools to Reduce Burnout, Bost Patient Experience
What You Should Know:
- Tampa General Hospital (TGH) is embracing artificial intelligence (AI) to streamline documentation workflows and empower physicians to focus on what matters most – their patients.
- While thorough documentation is crucial for high-quality care, the process can be time-consuming and detract from valuable patient interactions. To address this challenge, TGH has partnered with Nuance to implement DAX Copilot, an innovative AI-powered solution.
DAX Copilot:
Read More
CCS Unveils AI Predictive Model to Predict & Improves CGM Adherence in Diabetes Management
What You Should Know:
- CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee™ a new, AI-powered predictive model for healthcare organizations focused on improving adherence in the population of people that have been prescribed a continuous glucose monitoring (CGM) device to help manage their
Read More
KARL STORZ to Acquire Asensus Surgical for $0.35 per Share
What You Should Know:
- Asensus Surgical, Inc. (NYSE American: ASXC), a leading developer of digital surgical technologies, announced today it has entered into a definitive merger agreement with KARL STORZ Endoscopy-America, Inc., a subsidiary of the global medical technology company KARL STORZ SE & Co. KG.
- Asensus Surgical is a pioneer in digital surgery, developing the first intra-operative Augmented Intelligence technology approved for global use. Their LUNA system,
Read More
Nearly 70% of High-Risk Patients Unaware of Chronic Kidney Disease Risk, Study Finds
What You Should Know:
- A new study by Phreesia and the National Kidney Foundation (NKF) reveals a troubling gap in awareness of chronic kidney disease (CKD) among high-risk patients. Published in The American Journal of Accountable Care, the research highlights the importance of patient-provider communication and patient activation in early detection and prevention of CKD, a leading cause of death in the United States.
- The research emphasizes the value of patient education and
Read More
Teladoc Health Appoints Charles “Chuck” Divita as New CEO
What You Should Know:
- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, has announced the appointment of Charles “Chuck” Divita, III, as Chief Executive Officer, effective immediately.
- Alongside his role as CEO, Divita has also joined Teladoc Health’s Board of Directors.
Divita Bio/Background
Divita transitions to Teladoc Health from GuideWell, a prominent health solutions organization that includes Florida Blue, Florida's leading
Read More
Blood Test for Alzheimer’s on the Horizon: ALZpath Licenses pTau217 Antibody to Roche
What You Should Know:
- ALZpath, a leader in Alzheimer's disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer's disease using Roche's widely used Elecsys® platform.
- The Roche pTau217 test has already received Breakthrough Device designation from the FDA and will be commercialized as part of a collaboration between Roche and Eli Lilly.
pTau217: A Game Changer in
Read More
Anterior Secures $20M to Streamline Healthcare Administration with GenAI
What You Should Know:
- Anterior, a healthcare administration platform built by clinicians raises $20M in Series A funding round.
- Led by New Enterprise Associates (NEA), the round included participation from Sequoia Capital, Blue Lion Global, and Neo. Formerly known as Co:Helm, Anterior recently rebranded to reflect its focus on moving healthcare administration forward.
Unburdening Clinicians with AI
Anterior's mission is to free doctors and nurses from the
Read More
